Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec;92(6):2132-8.
doi: 10.1016/j.athoracsur.2011.06.061. Epub 2011 Oct 19.

Long-term mortality of coronary artery bypass grafting and bare-metal stenting

Chuntao Wu  1 , Songyang Zhao, Andrew S Wechsler, Stephen Lahey, Gary Walford, Alfred T Culliford, Jeffrey P Gold, Craig R Smith, David R Holmes Jr, Spencer B King 3rd, Robert S D Higgins, Desmond Jordan, Edward L Hannan
Affiliations

Long-term mortality of coronary artery bypass grafting and bare-metal stenting

Chuntao Wu et al. Ann Thorac Surg. 2011 Dec.

Abstract

Background: There is little information on relative survival with follow-up longer than 5 years in patients undergoing coronary artery bypass grafting (CABG) and patients undergoing percutaneous coronary intervention (PCI) with stenting. This study tested the hypothesis that CABG is associated with a lower risk of long-term (8-year) mortality than is stenting with bare-metal stents for multivessel coronary disease.

Methods: We identified 18,359 patients with multivessel disease who underwent isolated CABG and 13,377 patients who received bare-metal stenting in 1999 to 2000 in New York and followed their vital status through 2007 using the National Death Index (NDI). We matched CABG and stent patients on the number of diseased coronary vessels, proximal left anterior descending (LAD) artery disease, and propensity of undergoing CABG based on numerous patient characteristics and compared survival after the 2 procedures.

Results: In the 7,235 pairs of matched patients, the overall 8-year survival rates were 78.0% for CABG and 71.2% for stenting (hazard ratio [HR], 0.68; 95% confidence interval [CI], 0.64 to 0.74; p < 0.001). For anatomic groups classified by the number of diseased vessels and proximal LAD involvement, the HRs ranged from 0.53 (p < 0.001) for patients with 3-vessel disease involving proximal LAD artery disease to 0.78 (p = 0.05) for patients with 2-vessel disease but no disease in the LAD artery. A lower risk of death after CABG was observed in all subgroups stratified by a number of baseline risk factors.

Conclusions: Coronary artery bypass grafting is associated with a lower risk of death than is stenting with bare metal stents for multivessel coronary disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(Panels A–F). Kaplan-Meier survival curves for propensity matched CABG and stenting patients.
Figure 1
Figure 1
(Panels A–F). Kaplan-Meier survival curves for propensity matched CABG and stenting patients.
Figure 1
Figure 1
(Panels A–F). Kaplan-Meier survival curves for propensity matched CABG and stenting patients.
Figure 1
Figure 1
(Panels A–F). Kaplan-Meier survival curves for propensity matched CABG and stenting patients.
Figure 1
Figure 1
(Panels A–F). Kaplan-Meier survival curves for propensity matched CABG and stenting patients.
Figure 1
Figure 1
(Panels A–F). Kaplan-Meier survival curves for propensity matched CABG and stenting patients.
See this image and copyright information in PMC

Comment in

  • Invited commentary.
    Taggart D. Taggart D. Ann Thorac Surg. 2011 Dec;92(6):2138-9. doi: 10.1016/j.athoracsur.2011.07.008. Ann Thorac Surg. 2011. PMID: 22115226 No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Serruys PW, Morice M-C, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. New England Journal of Medicine. 2009;360:961–972. - PubMed
    1. Serruys PW, Ong ATL, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease - The final analysis of the arterial revascularization therapies study (ARTS) randomized trial. Journal of the American College of Cardiology. 2005;46:575–581. - PubMed
    1. Rodriguez AE, Baldi J, Pereira CF, et al. Five-year follow-up of the argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II) Journal of the American College of Cardiology. 2005;46:582–588. - PubMed
    1. Hueb W, Lopes N, Gersh BJ, et al. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II) A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010;122:949–957. - PubMed
    1. Booth J, Clayton T, Pepper J, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease - Six-year follow-up from the stent or surgery trial (SoS) Circulation. 2008;118:381–388. - PubMed

Publication types